US 10738123
Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia
granted A61KA61K2039/505A61K2039/54
Quick answer
US patent 10738123 (Anti-FLT-1 antibodies in treating bronchopulmonary dysplasia) held by The Regents of the University of Colorado, a Body Corporate expires Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Aug 11 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 06 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2039/505, A61K2039/54, A61K2039/545, A61K31/07